M
Marina Amaral de Ávila Machado
Researcher at McGill University
Publications - 19
Citations - 409
Marina Amaral de Ávila Machado is an academic researcher from McGill University. The author has contributed to research in topics: Adalimumab & Infliximab. The author has an hindex of 8, co-authored 19 publications receiving 339 citations. Previous affiliations of Marina Amaral de Ávila Machado include McGill University Health Centre & Universidade Federal de Minas Gerais.
Papers
More filters
Journal ArticleDOI
Judicialização do acesso a medicamentos no Estado de Minas Gerais, Brasil
Marina Amaral de Ávila Machado,Francisco de Assis Acurcio,Cristina Mariano Ruas Brandão,Daniel Resende Faleiros,Augusto Afonso Guerra,Mariângela Leal Cherchiglia,Eli Iola Gurgel Andrade +6 more
TL;DR: In this paper, analisar o perfil dos requerentes e dos medicamentos pleiteados em acoes judiciais is presented, analysing a perfil of requerente e dos pleiteado in acoes.
Journal ArticleDOI
Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis.
Marina Amaral de Ávila Machado,Mariana Michel Barbosa,Alessandra Maciel Almeida,Vânia Eloisa de Araújo,Adriana Maria Kakehasi,Eli Iola Gurgel Andrade,Mariangela Leal Cherchiglia,Francisco de Assis Acurcio +7 more
TL;DR: A systematic review of randomized clinical trials on adult patients with ankylosing spondylitis found that adalimumab, infliximab, etanercept, adalimusab, golimumAB, and golimumab can effectively reduce the signs and symptoms of the axial component of ankyLosing spONDylitis.
Journal ArticleDOI
Médicos, advogados e indústria farmacêutica na judicialização da saúde em Minas Gerais, Brasil
Orozimbo Henriques Campos Neto,Francisco de Assis Acurcio,Marina Amaral de Ávila Machado,Felipe Ferré,Fernanda Loureiro Vasconcelos Barbosa,Mariângela Leal Cherchiglia,Eli Iola Gurgel Andrade +6 more
TL;DR: In this paper, a study of acoes judiciais against o Estado de Minas Gerais was carried out, focusing on the relationship between medico prescritor, advogado, and industry farmaceutica.
Journal ArticleDOI
Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.
Marina Amaral de Ávila Machado,Cristiano Soares de Moura,Steve Ferreira Guerra,Jeffrey R. Curtis,Michal Abrahamowicz,Sasha Bernatsky +5 more
TL;DR: In patients with RA previously treated with methotrexate, the comparisons of tofacitinib with non-TNF biologics, though not definitive, did not demonstrate differences with respect to hospitalized infections or effectiveness.
Journal ArticleDOI
Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis
Marina Amaral de Ávila Machado,Marina Amaral de Ávila Machado,Cristiano Soares de Moura,Felipe Ferré,Sasha Bernatsky,Elham Rahme,Francisco de Assis Acurcio,Francisco de Assis Acurcio +7 more
TL;DR: A general trend of higher rates of therapy persistence with anti-TNF drugs and a higher persistence for DMARD in patients with rheumatoid arthritis as compared to ankylosing spondylitis was observed in the study period.